Search research articles
Contact Us
Filters
Showing results (31-40 of 100) with videos related to
Page
of 10
Sort By:
Nuklearmedizin. Nuclear Medicine
|
August 29, 2024
Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands
Laya Rahbar Nikoukar, Robert Seifert, David Ventura, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 16, 2018
<sup>18</sup>F-PSMA-1007 PET/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics
Kambiz Rahbar, Ali Afshar-Oromieh, Martin Bögemann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 21, 2018
Diagnostic performance of <sup>18</sup>F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
Kambiz Rahbar, Ali Afshar-Oromieh, Robert Seifert, et al.
Urologic Oncology
|
June 5, 2014
Preoperative prostate-specific antigen isoform p2PSA ≤ 22.5 pg/ml predicts advanced prostate cancer in patients undergoing radical prostatectomy
Okyaz Eminaga, Martin Bögemann, Bernhard Breil, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 19, 2017
<sup>177</sup>Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
Axel Bräuer, Lena Sophie Grubert, Wolfgang Roll, et al.
Clinical Genitourinary Cancer
|
November 6, 2025
Real-World Experience With Lenvatinib Plus Everolimus (LEN+EVE) in Patients With Pretreated Advanced Renal Cell Carcinoma (RELEVANCE): A Retrospective, Multicenter Case Series
Hendrik Eggers, Ramona Stelmacher, Martin Bögemann, et al.
Cancer Cell International
|
August 27, 2025
Molecular analysis of androgen receptor splice variant AR-V3 reveals eminent ambiguity regarding activity and clinical utility
Neele Wüstmann, Verena Humberg, Julia Vieler, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research
|
October 2, 2025
Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer
Neele Wüstmann, Julissa Reimann, Julia Vieler, et al.
European Urology Focus
|
January 23, 2021
Prostate-specific Membrane Antigen-based Imaging of Castration-resistant Prostate Cancer
Manuel Weber, Boris Hadaschik, Justin Ferdinandus, et al.
Oncotarget
|
November 21, 2017
Comparison of isolation platforms for detection of circulating renal cell carcinoma cells
Yvonne Maertens, Verena Humberg, Franziska Erlmeier, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 100) with videos related to
Sort By:
Page
of 10
Nuklearmedizin. Nuclear Medicine
|
August 29, 2024
Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands
Laya Rahbar Nikoukar, Robert Seifert, David Ventura, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 16, 2018
<sup>18</sup>F-PSMA-1007 PET/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics
Kambiz Rahbar, Ali Afshar-Oromieh, Martin Bögemann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 21, 2018
Diagnostic performance of <sup>18</sup>F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
Kambiz Rahbar, Ali Afshar-Oromieh, Robert Seifert, et al.
Urologic Oncology
|
June 5, 2014
Preoperative prostate-specific antigen isoform p2PSA ≤ 22.5 pg/ml predicts advanced prostate cancer in patients undergoing radical prostatectomy
Okyaz Eminaga, Martin Bögemann, Bernhard Breil, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 19, 2017
<sup>177</sup>Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
Axel Bräuer, Lena Sophie Grubert, Wolfgang Roll, et al.
Clinical Genitourinary Cancer
|
November 6, 2025
Real-World Experience With Lenvatinib Plus Everolimus (LEN+EVE) in Patients With Pretreated Advanced Renal Cell Carcinoma (RELEVANCE): A Retrospective, Multicenter Case Series
Hendrik Eggers, Ramona Stelmacher, Martin Bögemann, et al.
Cancer Cell International
|
August 27, 2025
Molecular analysis of androgen receptor splice variant AR-V3 reveals eminent ambiguity regarding activity and clinical utility
Neele Wüstmann, Verena Humberg, Julia Vieler, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research
|
October 2, 2025
Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer
Neele Wüstmann, Julissa Reimann, Julia Vieler, et al.
European Urology Focus
|
January 23, 2021
Prostate-specific Membrane Antigen-based Imaging of Castration-resistant Prostate Cancer
Manuel Weber, Boris Hadaschik, Justin Ferdinandus, et al.
Oncotarget
|
November 21, 2017
Comparison of isolation platforms for detection of circulating renal cell carcinoma cells
Yvonne Maertens, Verena Humberg, Franziska Erlmeier, et al.
Page
of 10